Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Oclaro, Inc. (Avanex-Bookham) -- Ignore unavailable to you. Want to Upgrade?

To: Andy Yamaguchi who wrote (211)	3/1/2000 11:41:00 AM
From: Andy Yamaguchi	Read Replies (2) \| Respond to of 2293

after all the hpyes became clear, the best shot for AVNX's valuation would be 1/5 of ETEK's. There is no way that AVNX can have the equal market valuation of ETEK, unless they can catch up ETEK for product offerings-more than 50. Fiberoptics are all for OEM, the big one goes to bigger, the smaller one has to fight hardly to stay in business. AVNX is the one has to fight to stay in business. GLW/JDSU/ETEK are ones to get bigger and bigger.

To: Andy Yamaguchi who wrote (211)	3/1/2000 11:53:00 AM
From: mact	Read Replies (1) \| Respond to of 2293

from their S1 filing!!!!...andy, this is the second time u have lied!...enough is enough!...its one thing to offer constructive criticism but to lie is the type of fraudulant behavior that u supposedly despise..if anvx representatives read ur posts, perhaps there might be be legal repucussions afterall. MANUFACTURING We currently manufacture all of our products in our Fremont, California facility. We intend to devote significant resources to expanding our manufacturing capacity and expect to continue to hire significant numbers of new manufacturing employees. The manufacturing of photonic processors requires the use of a highly skilled manual workforce performing critical functions such as optical assembly, optical alignment, soldering and component integration. We invest significant resources in training and maintaining the quality of our manufacturing work force. Furthermore, we developed proprietary automated testing equipment for consistency in testing results and for efficiency. We also have grouped our manufacturing operations into several product-specific or customer-specific cells. We believe this provides a highly flexible and efficient operating capability, and is designed to meet customer expectations for high volume capacity, high quality and on-time delivery. If we are unable to expand our manufacturing capacity on a timely basis to meet demand or if we do not accurately project demand, we will have excess capacity or insufficient capacity, either of which will seriously harm our business. We emphasize quality assurance throughout the entire supply-chain and manufacturing processes. We also install stringent quality control processes and procedures, including incoming material inspection, in-process testing and outgoing inspection. We have entered into a five-year agreement with CMI under which a subsidiary of CMI, organized under the laws of the People's Republic of China, manufactures optical subcomponents for us in limited quantities at a small facility in Tianjin, China. They are building a new, larger manufacturing facility in Tianjin, which will not be operational until at least the quarter ending September 29, 2000. We cannot assure you that this larger facility will be completed on time or at all. Under the agreement with CMI, we have granted licenses to CMI to make in China and the United States, and to use and sell worldwide, the licensed components. We also granted them a license to use some of our technical information and manufacturing process know-how in China and the United States. These licenses are exclusive in China and non-exclusive elsewhere. As a result, CMI can manufacture and sell optical components based on our technology to third parties, including our potential competitors. We expect CMI to build a significant portion of our subcomponents and products in the future. These activities will extend to full production and include activities such as material procurement, assembly, test and 40 control. We will design, specify and monitor all of the tests that are required to meet our quality standards. We believe this arrangement with CMI will allow us to operate without dedicating additional space to these manufacturing operations and will conserve the working capital that would otherwise be required for funding additional inventory. See "Risk Factors -- Because We Expect to Depend on a Third Party Located in China to Manufacture Subcomponents and Products for Us, We May Encounter Difficulties in Obtaining a Sufficient Amount of High Quality Products."